Anemia in women of reproductive age in current clinical practice and effectiveness of iron fumarate combined with folate

Iron deficiency anemia (IDA) and latent iron deficiency are common. The article describes the mechanisms of development, diagnostic criteria, the clinical presentation of the IDA. The current options for treating anemia with oral iron supplements and their indications, effectiveness and safety crite...

Full description

Bibliographic Details
Main Authors: Viktor G. Sturov, Nikolay I. Melchenko, Anastasya S. Balysheva
Format: Article
Language:Russian
Published: IP Berlin A.V. 2023-04-01
Series:Гинекология
Subjects:
Online Access:https://gynecology.orscience.ru/2079-5831/article/viewFile/352504/118510
_version_ 1797834039680303104
author Viktor G. Sturov
Nikolay I. Melchenko
Anastasya S. Balysheva
author_facet Viktor G. Sturov
Nikolay I. Melchenko
Anastasya S. Balysheva
author_sort Viktor G. Sturov
collection DOAJ
description Iron deficiency anemia (IDA) and latent iron deficiency are common. The article describes the mechanisms of development, diagnostic criteria, the clinical presentation of the IDA. The current options for treating anemia with oral iron supplements and their indications, effectiveness and safety criteria. Aim. To analyze and prove the effectiveness of iron fumarate combined with folate for treating and preventing iron deficiency in women of reproductive age. Materials and methods. Sixty women aged 1847 with mild to moderate iron deficiency were examined. All patients received of iron fumarate (equivalent to 150 mg of elemental iron) combined with 1500 mcg of folic acid for 2142 days. Hemoglobin, ferritin, serum iron, and erythrocyte indices were measured. Results. In most patients, recovery from anemia was observed: an increase in hemoglobin by 2732% and ferritin by a mean of 35%, i.e., 1.67 times compared with alternative iron therapy (iron sulfate and gluconate). The rate of side effects was less than 4%. Conclusion. Co-administration of iron fumarate with folic acid has been shown to increase the therapeutic efficacy and has a high safety profile in patients with IDA (especially in pregnant women requiring additional folate supplements).
first_indexed 2024-04-09T14:32:16Z
format Article
id doaj.art-178c814e74424b16ac63f5943f53239b
institution Directory Open Access Journal
issn 2079-5696
2079-5831
language Russian
last_indexed 2024-04-09T14:32:16Z
publishDate 2023-04-01
publisher IP Berlin A.V.
record_format Article
series Гинекология
spelling doaj.art-178c814e74424b16ac63f5943f53239b2023-05-03T14:55:01ZrusIP Berlin A.V.Гинекология2079-56962079-58312023-04-01251727610.26442/20795696.2023.1.20211979499Anemia in women of reproductive age in current clinical practice and effectiveness of iron fumarate combined with folateViktor G. Sturov0https://orcid.org/0000-0001-8243-247XNikolay I. Melchenko1https://orcid.org/0000-0002-7547-998XAnastasya S. Balysheva2https://orcid.org/0000-0002-2895-6261Novosibirsk State UniversityNovosibirsk State UniversityNovosibirsk State UniversityIron deficiency anemia (IDA) and latent iron deficiency are common. The article describes the mechanisms of development, diagnostic criteria, the clinical presentation of the IDA. The current options for treating anemia with oral iron supplements and their indications, effectiveness and safety criteria. Aim. To analyze and prove the effectiveness of iron fumarate combined with folate for treating and preventing iron deficiency in women of reproductive age. Materials and methods. Sixty women aged 1847 with mild to moderate iron deficiency were examined. All patients received of iron fumarate (equivalent to 150 mg of elemental iron) combined with 1500 mcg of folic acid for 2142 days. Hemoglobin, ferritin, serum iron, and erythrocyte indices were measured. Results. In most patients, recovery from anemia was observed: an increase in hemoglobin by 2732% and ferritin by a mean of 35%, i.e., 1.67 times compared with alternative iron therapy (iron sulfate and gluconate). The rate of side effects was less than 4%. Conclusion. Co-administration of iron fumarate with folic acid has been shown to increase the therapeutic efficacy and has a high safety profile in patients with IDA (especially in pregnant women requiring additional folate supplements).https://gynecology.orscience.ru/2079-5831/article/viewFile/352504/118510iron deficiency anemialatent iron deficiencydiagnosisiron overloadtreatmentiron fumaratefolic acid
spellingShingle Viktor G. Sturov
Nikolay I. Melchenko
Anastasya S. Balysheva
Anemia in women of reproductive age in current clinical practice and effectiveness of iron fumarate combined with folate
Гинекология
iron deficiency anemia
latent iron deficiency
diagnosis
iron overload
treatment
iron fumarate
folic acid
title Anemia in women of reproductive age in current clinical practice and effectiveness of iron fumarate combined with folate
title_full Anemia in women of reproductive age in current clinical practice and effectiveness of iron fumarate combined with folate
title_fullStr Anemia in women of reproductive age in current clinical practice and effectiveness of iron fumarate combined with folate
title_full_unstemmed Anemia in women of reproductive age in current clinical practice and effectiveness of iron fumarate combined with folate
title_short Anemia in women of reproductive age in current clinical practice and effectiveness of iron fumarate combined with folate
title_sort anemia in women of reproductive age in current clinical practice and effectiveness of iron fumarate combined with folate
topic iron deficiency anemia
latent iron deficiency
diagnosis
iron overload
treatment
iron fumarate
folic acid
url https://gynecology.orscience.ru/2079-5831/article/viewFile/352504/118510
work_keys_str_mv AT viktorgsturov anemiainwomenofreproductiveageincurrentclinicalpracticeandeffectivenessofironfumaratecombinedwithfolate
AT nikolayimelchenko anemiainwomenofreproductiveageincurrentclinicalpracticeandeffectivenessofironfumaratecombinedwithfolate
AT anastasyasbalysheva anemiainwomenofreproductiveageincurrentclinicalpracticeandeffectivenessofironfumaratecombinedwithfolate